vimarsana.com
  1. Home
  2. Live Updates
  3. Early Relapsed Diffuse Largeb Cell Lymphoma - Breaking News

Early Relapsed Diffuse Largeb Cell Lymphoma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Pfizer Announces Positive Overall Survival in Phase 3 Trial of ADCETRIS® Regimen in Patients with Relapsed/​Refractory Diffuse Large B-cell Lymphoma (DLBCL)

ECHELON-3 trial of ADCETRIS in combination with lenalidomide and rituximab showed significant improvement in primary endpoint of overall survival and in secondary endpoints of progression free.

United statesRoger danseyDrug administrationExchange commissionPfizer incNational library of medicineLeukemia lymphoma societyChief development officerNorth americaPrescribing informationPfizer oncologyBreakthroughs that change patientAnnual reportLooking informationFactors that may affect futureDiffuse largeb cell

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.